Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Saudi Med J ; 30(1): 77-81, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19139778

RESUMO

OBJECTIVE: To compare dexmedetomidine with remifentanil in desflurane based ambulatory gynecologic laparoscopic surgery, in respect to its effects on orientation, discharge time, nausea-vomiting, and postoperative analgesic need. METHODS: Sixty 20-40 year old ASA I-II patients undergoing gynecologic laparoscopic surgery were randomized into 2 groups. This study was performed in the operating theaters of the Hacettepe University Faculty of Medicine, Hacettepe, Turkey in 2004 as a prospective, randomized, and double blinded study. The remifentanil group (group R), and dexmedetomidine group (group D) received a bolus of 1 microg/kg over 10 minutes, followed by 0.2 microg/kg/minute peroperative infusion of remifentanil, and 0.4 microg/kg/hour of dexmedetomidine. Hemodynamic parameters, time to extubation, and to orientation to person, place, and date, postoperative nausea, vomiting, pain, analgesic requirement at home, and satisfaction with anesthesia were recorded. RESULTS: Demographic, hemodynamic data, postoperative pain scores, and discharge time were similar in both groups. Time to extubation, to orientation to person, to place and date were shorter in group R. Postoperative nausea, vomiting, and analgesic requirements at home were less in group D. CONCLUSION: This study demonstrated that dexmedetomidine infusion causes a relatively slow recovery with reduced postoperative nausea, vomiting, and analgesic requirements, and similar hemodynamics compared to remifentanil in ambulatory laparoscopic surgeries. It may be an alternative to remifentanil in ambulatory anesthesia.


Assuntos
Dexmedetomidina/administração & dosagem , Procedimentos Cirúrgicos em Ginecologia/métodos , Hipnóticos e Sedativos/administração & dosagem , Laparoscopia/métodos , Piperidinas/administração & dosagem , Procedimentos Cirúrgicos Ambulatórios , Método Duplo-Cego , Feminino , Humanos , Estudos Prospectivos , Remifentanil
2.
Saudi Med J ; 29(6): 841-6, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18521462

RESUMO

OBJECTIVES: To evaluate maternal and neonatal effects of desflurane compared with the sevoflurane for general anesthesia for cesarean section. METHODS: The study was conducted as a prospective randomized blind study between January 2003 to January 2004 at the Hacettepe University, Ankara, Turkey. One hundred and two American Society of Anesthesiologists (ASA) I patients aged between 20-35 at 37-42 weeks of pregnancy were randomly allocated into 2 groups. All patients received thiopental and succinylcholine for induction. Patients assigned to the first group received desflurane 2.5%, and the second group sevoflurane 1.5% combined with 50% nitrous oxide and oxygen. Maternal blood loss, umbilical arterial blood gas values, delivery intervals, Apgar scores, and neurologic and adaptive capacity score (NACS) on the fifteenth minute, second hour, and twenty-fourth hour of age were evaluated to assess the neonatal status. RESULTS: One hundred and two (52 sevoflurane group, 50 desflurane group) parturients were included in the study. In the desflurane group, NACS were significantly better on the fifteenth minute and second hour evaluations. There were no statistically significant differences in twenty-fourth hour NACS evaluations, Apgar scores, umbilical arterial blood gas values, delivery times, and maternal blood loss between the groups. CONCLUSION: Desflurane anesthesia offers more favorable results compared to sevoflurane in newborns delivered by elective cesarean section under general anesthesia in the early hours after delivery.


Assuntos
Adaptação Fisiológica/efeitos dos fármacos , Anestesia Obstétrica , Anestésicos Inalatórios/farmacologia , Recém-Nascido/fisiologia , Isoflurano/análogos & derivados , Éteres Metílicos/farmacologia , Sistema Nervoso/efeitos dos fármacos , Adulto , Cesárea , Desflurano , Feminino , Humanos , Isoflurano/farmacologia , Gravidez , Estudos Prospectivos , Sevoflurano
3.
Saudi Med J ; 27(5): 642-5, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16680253

RESUMO

OBJECTIVE: To evaluate the preemptive effects of diclofenac sodium, in combination with remifentanil and ketamine. METHODS: A prospective, randomized, double blind, placebo-controlled trial was carried out at the Hacettepe University Hospital, Ankara, Turkey from September to December 2004. Forty-three, American Society of Anesthesiology physical status group I-II women, aged >18 years, who would undergo both diagnostic and operative laparoscopic surgery were randomly assigned into 2 groups. All patients received intraoperative 0.1 microg x kg(-1)min(-1) remifentanil infusion. Diclofenac (1 mg x kg(-1) intramuscular) was administered, 20 minutes before the operation. Ketamine (0.8 mg x kg(-)1 intravenously) was administered 5 minutes before the skin incision and at completion of skin closure. We divided the patients into 2 groups; Group I (diclofenac + remifentanil + ketamine), Group II (remifentanil + ketamine). Pain was evaluated postoperatively using the visual analogue scale (VAS) while global satisfaction by verbal rating scale (VRS). RESULTS: All 43 female patients have a mean +/- SD age of 32.3 +/- 6.5 years, height of 163 +/- 5.3 cm, and weight of 62.9 +/- 9.5 kg. The VAS and VRS scores and also time to first analgesic request were not different between the groups. In all groups, >98% of the patients were satisfied or very satisfied. CONCLUSION: We have not found any preemptive or additive effect of diclofenac sodium with the concomitant use of ketamine.


Assuntos
Analgésicos Opioides/administração & dosagem , Anestésicos Dissociativos/administração & dosagem , Anti-Inflamatórios não Esteroides/administração & dosagem , Diclofenaco/administração & dosagem , Genitália Feminina/cirurgia , Ketamina/administração & dosagem , Laparoscópios , Dor Pós-Operatória/prevenção & controle , Piperidinas/administração & dosagem , Adulto , Método Duplo-Cego , Feminino , Humanos , Estudos Prospectivos , Remifentanil , Turquia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA